Obesity App May Enable Weight Loss With Less Semaglutide

A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial results with less than half the dose.
Medscape Medical News

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top